NEW YORK / LONDON (IT BOLTWISE) – Hims & Hers Health shares recently fell despite the company reporting impressive quarterly results. The share price fell 1.4 percent to $47.54, reflecting uncertainty in the market environment. Despite an increase in sales of over 72 percent compared to the previous year, the price remains under pressure.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
Hims & Hers Health shares recently experienced a decline despite the company reporting impressive quarterly results. The share price fell 1.4 percent to $47.54, reflecting uncertainty in the market environment. Despite an increase in sales of over 72 percent compared to the previous year, the price remains under pressure.
On February 20, 2025, the stock reached its 52-week high of $72.98. To reach this level again, the price would have to rise by more than 53 percent. The lowest level in the last 52 weeks was recorded on November 1, 2024 at $18.33, representing a decline of over 61 percent from the current price.
However, the latest quarterly figures show a positive picture: Earnings per share rose from USD 0.06 in the same quarter last year to USD 0.17. Revenue for the quarter was $544.83 million, up 72.61 percent year-over-year. These figures underline the company’s growth momentum, which is, however, not enough to alleviate the current share price pressure.
Analysts forecast 2025 EPS of $0.568 per share. The next quarterly report is expected on November 3, 2025, which could provide further insights into the company’s financial performance. Despite the positive financial performance, the stock remains under pressure due to external market conditions.
*Order an Amazon credit card with no annual fee with a credit limit of 2,000 euros! a‿z
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Hims & Hers Health: share price under pressure despite positive quarterly figures”.
The post Share price under pressure despite positive quarterly figures appeared first on Veritas News.
